Use the information below to learn why TAKHZYRO is a proven preventive treatment for HAE and how to create effective HAE management plans for your patients. You'll also find resources you can share with your patients and their caregivers to help them start and stay on TAKHZYRO.
Generally, a prior authorization (PA) will be required for treatment to begin, and Takeda Patient Support may contact your office to share additional information that will help you complete this process. Refer to the Benefits Verification Checklist for a list of the necessary information your patient may need when submitting a PA.
Understand the burden of HAE further
Looking for more information about TAKHZYRO? These materials are a good place to start. You can also sign up to get more resources delivered straight to your inbox. And if you’re taking care of a loved one with HAE, you can find helpful resources here.
Hereditary Angioedema (HAE) Assessment Questionnaire for Patients
Use this comprehensive list of questions about HAE's impact on your patients to help guide your initial assessment.
Patient Case Study: Andrew
See why Andrew decided to start preventive treatment with TAKHZYRO after living for years with untreated swells.
Patient Case Study: Danny, a Trigger-Avoidant Patient
See why Danny, a patient who is trigger avoidant, started preventive treatment with TAKHZYRO after living with a low HAE attack history.
Dosing Flashcard
See the available dosing options to help meet patients' changing HAE needs.
TAKHZYRO Prescriber Guide
Learn about one of the largest prevention studies in HAE with the longest active treatment duration.1-5
Information for your patients
HAE Attack Plan
Fill out this form with your patient to help them explain HAE to others, including what steps to take in the event of an emergency.
Travel Letter
Print this form and have your patient fill it out so that they are always prepared to travel with TAKHZYRO.